Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL dependent mechanisms are most frequently associated with point mutations in tyrosine...

Full description

Saved in:
Bibliographic Details
Main Authors: Elias, Marjanu Hikmah, Baba, Abdul Aziz, Husin, Azlan, Abdullah, Abu Dzarr, Hassan, Rosline, Sim, Goh Ai, Wahid, S. Fadilah Abdul, Ankathil, Ravindran
Format: Artigo
Language:Inglês
Published: PAGEPress Publications 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555211/
https://ncbi.nlm.nih.gov/pubmed/23355941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2012.e23
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items